|Articles|November 1, 2016
- BioPharm International-11-01-2016
- Volume 29
- Issue 11
BioPharm International, November 2016 Issue (PDF)
Click the title above to open the BioPharm International November 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Biosimilars to Drive Modern Manufacturing Approachesover 8 years ago
The Human Factor in Inspectionsover 8 years ago
Development of a Technique for Quantifying Protein Degradationover 9 years ago
Improving Process-Scale Chromatographyover 9 years ago
Five Themes That Will Drive the CMO Industryover 9 years ago
Commercializing High-Concentration mAbsover 9 years ago
Managing Risk in Raw Material SourcingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
